There’s no getting high off the good ole green without THC, but what is THC and how does it work?
Most smokers have heard this buzzword before, but not many know its chemical composition or the science behind how THC affects that brain and body. Every cerebral buzz you feel from smoking a well-packed bowl or leisurely spliff is directly proportional to the cannabis plant’s THC concentration. But why is that? In this article, the experts at Honest Marijuana tell you all the dirty details you’ll need to know to become an authority on all things THC (at least in your own head). Along the way, we’ll discuss such essential topics as:
What is THC?
How was THC discovered?
How does THC affect your brain?
How does THC affect your body?
How does potency affect the experience?
What are some common ways to consume THC?
How is THC medicinal?
That’s a lot to cover! So light up a toke and get ready to tuck in as we unearth the secrets of one of nature’s best beauties.
What Is THC?
Delta-9-tetrahydrocannabinol (THC) is a chemical secreted by the glands of the marijuana plant. It is found in high doses around the reproductive organs, as well as in the resin glands of the bud or flower of the female pot plant.
Although THC is only one of 85 plus chemical compounds known as cannabinoids found in the cannabis plant, THC is the primary psychoactive ingredient. It takes almost all the credit for creating your cerebral high.
Whereas humans use THC to get high, marijuana plants use THC to fend off natural predators like parasites, bacteria, and viruses. THC doesn’t produce antibacterial properties in people but, CBG (cannabigerol) a non-psychoactive compound also found in cannabis, does. Dr. Mary Jane always makes sure we get exactly what we need from our weed.…
Daily cannabis use is associated with greater odds of retention in treatment among those addicted to opioids, according to a new study published in the journal Addiction, and epublished online by the National Institute of Health.
“Cannabis use is common among people on opioid agonist treatment (OAT), causing concern for some care providers”, states the study. “However, there is limited and conflicting evidence on the impact of cannabis use on OAT outcomes. Given the “critical role of retention in OAT in reducing opioid-related morbidity and mortality”, researchers “aimed to estimate the association of at least daily cannabis use on the likelihood of retention in treatment among people initiating OAT.” As a secondary aim researchers “tested the impacts of less frequent cannabis use.”
The study comprised a total of 820 people who use illicit drugs (PWUD), who initiated OAT between December 1996 and May 2016. . Participants were followed for a median of 81 month.
The primary outcome was retention in OAT, defined as remaining in OAT (methadone or buprenorphine/naloxone-based) for two consecutive 6-month follow-up periods, and the primary explanatory variable was cannabis use (at least daily versus less than daily) during the same 6-month period. “Confounders assessed included: socio-demographic characteristics, substance use patterns and social-structural exposures.”
In adjusted analysis, “at least daily cannabis use was positively associated with retention in OAT [adjusted odds ratio (aOR) = 1.21, 95% confidence interval (CI) = 1.04-1.41]. Our secondary analysis showed that compared with non-cannabis users, at least daily users had increased odds of retention in OAT (aOR = 1.20, 95% CI = 1.02-1.43), but not less than daily users (aOR = 1.00, 95% CI = 0.87-1.14).”
Researchers conclude from this that “Among people who use illicit drugs initiating opioid agonist treatment in Vancouver, at least daily cannabis use was associated with approximately 21% greater odds of retention in treatment compared with less than daily consumption.”
According to a new study published by the Journal of Pain Research, THC/CBD can have “remarkable analgesic capabilities” in the treatment of chronic refractory pain caused by failed back surgery syndrome.
“This study aimed to evaluate pain and its symptoms in patients with failed back surgery syndrome (FBSS) refractory to other therapies, treated with a combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), in association with spinal cord stimulation (SCS)”, states the study’s abstract. “Outpatients referred at Pain Unit of San Vincenzo Hospital in Taormina (Italy), between September 2014 and January 2016”, were evaluated.
For the study, eleven FBSS patients diagnosed with neuropathic pain, and suffering from moderate to severe chronic refractory pain and undergoing treatment with SCS and a combination of THC/CBD for 12 consecutive months, completed the Douleur Neuropathique 4 questionnaire.
“All the included patients discontinued previous unsuccessful therapy at least 2 months before the beginning of the cannabinoid therapy, with the exception of the SCS that was continued. Patients received a fixed dosage of cannabinoid agonists (THC/CBD) that could be increased subjective to pain control response.” A Brief Pain Inventory questionnaire “was administered to measure pain and its interference with characteristic dimensions of feelings and functions”, and the “duration of treatment with SCS and THC/CBD combination was 12 months.”
Researchers found that “Effective pain management as compared to baseline result was achieved in all the cases studied. The positive effect of cannabinoid agonists on refractory pain was maintained during the entire duration of treatment with minimal dosage titration. Pain perception, evaluated through numeric rating scale, decreased from a baseline mean value of 8.18±1.07-4.72±0.9 by the end of the study duration (12 months) (P<0.001).”
The study concludes by stating that “The results indicate that cannabinoid agonists (THC/CBD) can have remarkable analgesic capabilities, as adjuvant of SCS, for the treatment of chronic refractory pain of FBSS patients.”
From left: Vivien Azer, Debra Borchardt, Emily Paxhia, Jessica Billingsly, Jeannette Ward Horton, Cynthia Salarizadeh and Tahira Rehmatullah
“This is the most interesting investment concept today,” TV personality Jim Cramer said about the high-flying cannabis industry as he kicked off the Green Market Summit at New York’s World Trade Center on Sept. 14.
Industry experts shared a vision of legal cannabis as a trillion dollar-plus disruptor of the pharmaceutical, food and beverage industries as more Fortune 500 companies take aim at the sector. Panel topics focused on the economics of cannabis, reaching out to consumers and the potential for marijuana to become more mainstream.
One major theme of the one-day conference that drew about 200 people centered around the growing role of Fortune 500 companies in the space, such as Constellation Brands and Molson Coors.
“Rob Sands is a very smart guy,” Cramer said about Constellation’s CEO, who inked a $4 billion deal with Canopy Growth over the summer to produce non-alcoholic cannabis beverages in Canada. It’s the largest investment yet by any major company in cannabis, but more are expected. Constellation owns Corona, Mondavi and many other alcohol brands.
Northern Mariana Islands Governor Ralph DLG. Torres has signed HB 20-178, the Taulamwaar Sensible CNMI Cannabis Act of 2018, into law.
“Today, our people made history”, said Governor Torres is a public statement. “We took a stand to legalize marijuana in the CNMI for recreational, medical, and commercial use”.
Torres’ signature on the measure comes shortly after it passed the Senate 6-0-2; it passed the House in August 108-1-1.
The new law allows those 21 and older to possess up to an ounce of marijuana, while also possessing up to 16 ounces of marijuana infused food products and 72 ounces of marijuana infused liquids. Licensed cannabis retail outlets are authorized to distribute the plant.
Under the new law there must be a Cannabis Commission appointed within 30 days. Once formed, the commission will have 180 days to create and adopt rules for the program.
Gover Torres’ signature of HB 20-178 makes the Northern Mariana Islands the first US territory to legalize cannabis.
The remote U.S. territory of the Northern Mariana Islands is so far ahead of the mainland U.S., it’s already late evening there. And the Northern Mariana Islands are also far ahead of the mainland U.S. when it comes to reforming marijuana laws.
The Northern Marianas just made history when it became the first jurisdiction in the U.S. where a governing body enacted legislation to both end marijuana prohibition and establish a system of regulation to replace it! Earlier today, Gov. DLG Torres signed the Taulamwaar Sensible CNMI Cannabis Act of 2018, after it was approved overwhelmingly by the commonwealth’s House and Senate.
All eight state laws that legalized, taxed, and regulated marijuana passed by voter initiative. And earlier this year, the Vermont Legislature enacted a bill that legalized adult-use possession and cultivation of marijuana. However, unlike the Northern Marianas’, Vermont’s law doesn’t include sales. (MPP spearheaded six of those nine campaigns.)
We’re proud of our allies at Sensible CNMI and lawmakers in the Northern Marianas for crafting a comprehensive, thoughtful bill that includes home cultivation, micro-producers, and on-site consumption. And we were honored to play a supporting role.
Meanwhile, the New Jersey Legislature could enact a law to legalize and regulate marijuana soon. Please consider making a generous donation to MPP so we can convince lawmakers in other states and territories to follow the Northern Marianas’ lead!
State Senator Floyd Prozanski is one of the Oregon’s legislative leaders and chair of the State Senate’s judiciary committee. He’s been heavily involved in crafting the state’s social-use legislation as well as its retail medical-marijuana program. He’ll be appearing at the International Cannabis Business Conference (ICBC) in Portland on Sept. 28. We conducted this interview with on Sept. 14.
How is Oregon dealing with its reported marijuana surpluses and what some describe as excessive cultivation licensing?
In 2017, my Senate Bill 1042, which passed out of the Senate Judiciary Committee that I chair, was going to give the governor what I call a tool in her toolbox to be able to enter into compacts with adjacent, adjoining states that had marijuana programs, either or both medical and recreational, and allow for the flow of cannabis products across state lines. I believe Oregon that the quality and the strains we produce in the medical arena would be in high demand for patients and individuals in the adjacent states. Unfortunately, the Senate leadership moved it to another committee for more consideration and it was not able to get out of that committee.
You’re talking about making Oregon-grown cannabis available in adjoining legal states like California and Washington?
Yes. Clearly, what we’d be doing at that point would be establishing a method to allow for these transfers to occur that would not be in violation of interstate commerce. To do that, we would to move the product from the Oregon into one of the three adjacent states that do have marijuana programs: California, Nevada and Washington. It would have to be through ground transportation only, because the federal government regulates air travel and marine travel.
“Allow cannabis to be available throughout the country. That would take away all of the diversion issues.”
This would allow us to address a lot of the concerns the Feds have regarding illegal diversion, because we would …
Less than seven weeks remain until the November 6 general election. The winners will have the power to determine New Hampshire’s marijuana policies for the next two years, so it is critically important for supporters of cannabis legalization to become informed and active participants in this year’s election.
As our voter guide explains, there are many strong contrasts between candidates’ positions on marijuana policy. In the race for governor, Gov. Chris Sununu (R) has not yet been convinced to support legalization, but Molly Kelly (D) and Jilletta Jarvis (L) have both taken clear positions in support.
The outcome of state Senate races will also be critical for our success, and those contests are often determined by a very small number of votes. If you are able to volunteer to help a good Senate candidate win in your area, please consider doing so. This could end up making a big difference in November!
While the new bill to legalize and regulate marijuana has not yet been revealed to the public, lawmakers and the Murphy administration are reportedly close to reaching a deal. However, it is not yet clear what the legislature intends to do to help people who are still suffering from the collateral consequences of a prior marijuana conviction.
New Jersey has been hotly debating the best way to legalize, tax, and regulate cannabis since Gov. Phil Murphy made that an important part of his campaign in 2017. MPP continues to advocate for adopting the best practices of other states to ensure that legalization allows opportunities for people impacted by marijuana prohibition and small businesses, and we’re encouraged that these ideas are reportedly being included in the legislation.
Learn more about the campaign and make a donation here.
Last month, a team of grassroots activists beat the odds and succeeded in qualifying a ballot initiative to legalize marijuana for adults in North Dakota. With just a few weeks left until Election Day, they need our help. Today, MPP is endorsing their effort and urging allies to support Measure 3.
There’s a real chance North Dakotans could approve Measure 3, which would end prohibition and create a process to seal criminal records for nonviolent marijuana convictions, but polling suggests the vote is going to be very close. Every dollar the campaign receives goes towards voter outreach and education. North Dakota has a small population, so your contribution could make all the difference.
A victory for Measure 3 would be huge. It would show that adult-use legalization can win anywhere, even in more rural and conservative states. It would also send a strong message to Congress that federal laws on marijuana are deeply unpopular throughout the country.
2018 is shaping up to be a big year for our movement. There are four marijuana-related state ballot questions in play, and each of them needs your help. Click the logos below to check out the campaigns. Please follow them on social media, spread the word to voters in those states, and donate what you can.
The Maryland Cannabis Policy Coalition just updated our voter guide for Maryland’s general election on Tuesday, November 6, 2018. All 188 of Maryland’s lawmakers are up for election this year, and we’ve graded the marijuana policy positions of those that responded to our candidate survey. We hope this guide is helpful as you prepare to vote!
Unfortunately, Republican candidate (and current governor) Larry Hogan’s views on the topic are not entirely clear. Please help us get his position firmly on the record! Consider attending a campaign event (listed on his Facebook page or Eventbrite) and respectfully asking him to explain his views. Or, you can send him an email. If you get a response, or just hear him comment on marijuana policy reform, please let us know.
And of course, don’t forget to register to vote! You must register by October 16, 2018 to vote in this election.
Both cannabidiolic acid (CBDA) and tetrahydrocannabinol (THC) show anti-inflammatory and anti-hyperalgesia effects on acute inflammation, according to a new study published by the journal Psychopharmacology, and epublished ahead of print by the National Institute of Health.
“The present study evaluates the anti-inflammatory and anti-hyperalgesia effects of CBD’s potent acidic precursor, cannabidiolic acid (CBDA), in a rodent model of carrageenan-induced acute inflammation in the rat hind paw, when administered systemically (intraperitoneal, i.p.) or orally before and/or after carrageenan”, begins the study’s abstract. “In addition, we assess the effects of oral administration of THC or CBDA, their mechanism of action, and the efficacy of combined ineffective doses of THC and CBDA in this model. Finally, we compare the efficacy of CBD and CBDA.”
Researchers found that “CBDA given i.p. 60 min prior to carrageenan (but not 60 min after carrageenan) produced dose-dependent anti-hyperalgesia and anti-inflammatory effects. In addition, THC or CBDA given by oral gavage 60 min prior to carrageenan produced anti-hyperalgesia effects, and THC reduced inflammation.”
The anti-hyperalgesia effects of THC “were blocked by SR141716 (a cannabinoid 1 receptor antagonist), while CBDA’s effects were blocked by AMG9810 (a transient receptor potential cation channel subfamily V member 1 antagonist). In comparison to CBDA, an equivalent low dose of CBD did not reduce hyperalgesia, suggesting that CBDA is more potent than CBD for this indication.”
Interestingly, “when ineffective doses of CBDA or THC alone were combined, this combination produced an anti-hyperalgesia effect and reduced inflammation.”
The study concludes by stating that “CBDA or THC alone, as well as very low doses of combined CBDA and THC, has anti-inflammatory and anti-hyperalgesia effects in this animal model of acute inflammation.”
The full study, conducted by researchers at the University of Guelph in Canada, can be found by clicking here.
While the US boasts the largest economy and stock market in the world, with giants Apple, Netflix and Google, Canada offers the largest cannabis companies for now.
To be sure, US cannabis companies such as MedMen Enterprises Inc. and Terra Tech Corp. have been expanding quickly. But Canada’s Tilray Inc., Canopy Growth Corp., Aurora Cannabis Inc., Aphria Inc., Cronos Group Inc. and others have bulked up significantly. The leading Canadian company, British Columbia-based Tilray, is currently valued at $14.4 billion.
With adult-use sales scheduled to begin in Canada on October 17, the spigot of capital has opened as investors pour money into the nation’s top pot stocks. The total cannabis market in Canada, including medical and recreational products, may yield up to $5.4 billion (C$7.2 billion) in sales next year, according to estimates from Deloitte.
With an eye on this growth, financiers and executives have been eager to offer investors new options. Tilray’s shares jumped 30% in their stock market debut on the NASDAQ on July 19, giving the company a total market value of $2.7 billion at the time. It’s a rich price tag for a business on track to earn just $80 million this year.
Market cap: $14.5 billion; owns Ontario-based LP, Tweed; with it’s recent $4 billion investment, Constellations Brands, whose stable of alcohol companies includes Corona and Mondavi, now owns 38% of Canopy.
Market cap: $7.3 billion; Alberta-based LP also owns Ontario-based LP, MedRelief Corp. as well as subsidiaries CannaMed and Hempco Food and Fiber; on Sept. 17, it was reported that Coca-Cola had contacted Aurora about launching a CBD soft drink in Canada.
A hemp legalization bill has been passed by a key Senate committee in New Jersey.
The Senate Economic Growth Committee passed Senate Bill 2491 today, sending it towards a vote by the full Senate. A companion bill to this measure, Assembly Bill 1330, was passed unanimously through the Assembly (67 to 0) in June.
According to its official text, SB 2491 “establishes an industrial hemp license for planting, growing, harvesting, possessing, processing, distributing, buying, or selling industrial hemp in the State.” The bill also “establishes procedures and requirements for persons applying to the Secretary of Agriculture for a license, including procedures and requirements for fingerprinting and criminal background checks for license applicants.”
The proposal defines industrial hemp as “an agricultural product that is part of the plant of any variety of Cannabis sativa L. with a delta-9-tetrahydrocannabinol concentration of 0.3% or less on a dry weight basis, and that is permitted pursuant to this act to be planted, grown, harvested, possessed, processed, distributed, bought, or sold by a person licensed pursuant to section 3 of this act.”
Louisiana state officials today nixed a regulation that prohibited physicians from recommending medical cannabis to more than 100 patients, while also easing renewal requirements for patients.
Earlier today the Louisiana Board of Medical Examiners, by a vote of 8 to 1, decided to remove an arbitrary rule that required physicians to stop recommending medical cannabis once they’ve recommended the medicine to 100 patients. The board also removed a requirement for patients to see their physician every 90 days in order to continue their ability to legally use medical cannabis (the vote on this was closer; 5 to 4).
Dr. Victor Chou, who was one of the first physicians in the state receive a license to recommend medical marijuana, told the board he met the patient cap just two weeks after opening his clinic, noting that he has “a waiting list of 700 patients”.
During their meeting the board was also asked to lift a rule that requires minors using the medicine to treat the symptoms of autism spectrum disorder to see a pediatric subspecialist in addition to their family physician. Proponents of the change urged the board to look into the issue at their next meeting which takes place in October.
Anxiety is a crippling mental disorder that affects more and more people every day. Even though this condition originates in the brain, it can have profound effects on the body as well. Anxiety can result in:
Numb or tingling hands.
Decreased blood flow.
And that’s just the tip of the anxiety-induced iceberg. Thankfully, treatments do exist for this crippling disease. But to add insult to serious injury, many of the treatments for anxiety produce side effects that are worse than the disorder itself.
Now, though, researchers are finding a treatment from an unlikely source: the marijuana plant. Certain chemicals in the marijuana plant can offer some seriously profound medical benefits when taken in the right way.
In this article, the experts at Honest Marijuana will introduce you to the chief chemical compound, known as CBD, that’s responsible for treating the many forms of anxiety. Along the way, we’ll answer such questions as:
What is CBD?
What is CBD oil?
Why use CBD oil for anxiety?
Is CBD oil addictive?
We’ll also investigate whether CBD oil gets you high and which CBD oil is right for treating anxiety. Let’s get started.
What Is CBD?
CBD is the abbreviation for the word cannabidiol (pronounced can-uh-BIH-dee-all), which is a member of a larger group of chemical compounds known as cannabinoids (pronounced CAN-uh-bih-noids).
Though you may have never heard of CBD or cannabinoids before, you’ve likely heard of CBD’s close relative THC. THC, or tetrahydrocannabinol, is the cannabinoid most responsible (and most famous) for getting you high. Other cannabinoids include:
All in all, 113 cannabinoids have been isolated from the three species of Cannabis plant (indica, sativa, and ruderalis). Though THC usually gets most of the press, CBD is quickly growing in popularity because of its myriad medical benefits.
Marijuana may help fight obesity, according to a new study published by the International Journal of Molecular Science.
Noting that “Obesity is an increasing health problem worldwide” and its “related comorbidities imply a high cost for the National Health System and diminish a patient’s life quality”, the study’s abstract states that”Cannabinoid receptors (CB) regulate thermogenesis, food intake and inflammation”.
In this study researchers found that “Stimulation of CB2 limits inflammation and promotes anti-obesity effects by reducing food intake and weight gain.” Stimulation of the CB2 receptors, of course, can occur through the consumption of cannabis and cannabinoids.”
The study’s full abstract can be found below:
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for the National Health System and diminish a patient’s life quality. Adipose tissue is composed of three types of cells. White adipocytes are involved in fat storage and secretion of hormones. Brown adipocytes are involved in thermogenesis and caloric expenditure. Beige adipocytes are transitional adipocytes that in response to various stimuli can turn from white to brown and could be protective against the obesity, enhancing energy expenditure. The conversion of white in beige adipose tissue is a potential new therapeutic target for obesity. Cannabinoid receptors (CB) regulate thermogenesis, food intake and inflammation. CB1 ablation or inhibition helps reducing body weight and food intake. Stimulation of CB2 limits inflammation and promotes anti-obesity effects by reducing food intake and weight gain. Its genetic ablation results in adiposity development. CB receptors are also responsible for transforming white adipose tissue towards beige or brown adipocytes, therefore their modulation can be considered potential anti-obesity target. CB1 principal localization in central nervous system represents an important limit. Stimulation of CB2, principally localized on peripheral cells instead, should facilitate the anti-obesity effects without exerting remarkable psychotropic activity.
If smoking marijuana is the king of all consumption methods, eating (i.e., ingesting) marijuana is the queen. Sure, dabbing (the prince in this metaphor) may usurp the throne one day, but for now, smoking and ingesting rule the roost. But before you head to the kitchen to dump your bag of weed into you favorite brownie mix, there are some important points to consider in your quest to learn how to make edibles.
But before you head to the kitchen and dump a bag of weed into your favorite brownie mix, there are some important points to consider. So that’s what we’re going to focus on in this article. Along the way, we’ll discuss:
What effects you can expect from eating cannabis
Why you should never dump raw bud into your food
The importance of decarboxylating your weed first
After that, we’ll show you how to make a cannabis infusion that you can use in any recipe and give you some tips on how to make edibles the honest way.
We’ll also let you in on a few super-secret methods (not really) for bringing you back down to earth should you get too high. Before we get to that, though, let’s start with what you can expect after eating marijuana edibles.
Effects Of Eating Cannabis
In terms of delivery, smoking and ingesting can be thought of, respectively, as the bullet train and the bike of the cannabis consumption world.
Smoking marijuana delivers the THC to your system lickety-split and takes you from normal to high in a matter of minutes or even seconds (like a bullet train). Ingesting marijuana, on the other hand, takes anywhere from 30 minutes to three or more hours to get you where you want to go (like a bike).
Additionally, when compared to smoking marijuana, ingesting your weed results in a much more intense high. To add to the appeal of ingesting, the effects …
The language of marijuana is a veritable goldmine of wacky verbiage. From airplane and angola to swag and sticky icky, there’s literally a slang term for every situation. Most of these terms can be used interchangeably as the mood hits, but some common words have very specific meanings and should be used only when the right conditions are met.
Case in point: the terms blunt and joint. Along with a few others, they may be the most common words in the cannabis dictionary. But do you know the difference between blunt vs. joint? The answer might surprise you.
Even though cannabis enthusiasts are a pretty laid-back bunch, using the wrong language can be a definite give-away that you’re inexperienced or “unedumacated.” The difference between blunt vs. joint is a prime example. Sure, they both contain marijuana, but that’s where the similarities end. What’s more, there are some pretty distinct differences that set one apart from the other.
To illustrate, it’s like the difference between a car and a truck. Yes, they both have four wheels and an engine, but you’re going to get some pretty strange looks if you point at a Mazda Miata and call it a Chevy Silverado. The terms just don’t mix. The same is true for a blunt and a joint.
Not sure what makes a blunt a blunt and a joint a joint? That’s why we’re here. So sit back, relax, and prepare to be informed.
What Is A Joint?
To help you understand the differences between a blunt and a joint, we’re going to break down the construction into smaller components. We’ll focus on:
This will give you some points of reference for comparison and help you see what makes each one unique.
The interior of a joint is exclusively marijuana. No extra stuff in here, man! It can be whatever strain …
A resolution urging the federal government to allow banks to work with marijuana businesses that are legal under state law has been passed by an Assembly committee in New Jersey.
The Assembly Financial Institutions and Insurance Committee gave approval yesterday to Assembly Resolution 183, which urges Congress to pass the federal “Secure and Fair Enforcement (SAFE) Banking Act of 2017.” According to the resolution, this bill would prohibit “federal bank regulators from punishing banks that service marijuana businesses and by prohibiting federal bank regulators from discouraging banks to do business with marijuana companies”, which would “improve public safety in New Jersey and would allow marijuana businesses to fully utilize the banking services offered in the State.”
The resolution notes that “New Jersey, like many other states, allows for the production and sale of marijuana for medicinal purposes. Marijuana is effective in treating pain, muscle stiffness, nausea, lack of appetite, and other symptoms associated with serious illnesses like cancer, AIDS, and multiple sclerosis.” The resolution states that the legalization of medical marijuana “has been endorsed by the American College of Physicians, the American Nurses Association, the American Academy of HIV Medicine, the HIV Medicine Association, and many other medical organizations.”
The resolution continues; “However, current federal law makes it difficult for persons engaged in the medicinal marijuana trade to keep their business’s assets in banks, since both the persons engaged in the medicinal marijuana trade and the banks fear reprisal from the federal government. This causes many people engaged in the medicinal marijuana trade to keep their business assets entirely in cash. This is dangerous, since it encourages armed robbery and other crimes against these businesses. It is also inefficient, since it involves counting and transporting large amounts of cash, and it excludes this capital from the market.”
The full text of Assembly Resolution 183 can be found by clicking here.
The New Jersey Department of Health has waived regulations prohibiting medical cannabis dispensaries from selling vaporizer products such as cannabis vape cartridges and vape pens.
A cannabis oil vape cartridge (photo: GamonWeed.com)
Up until this point medical cannabis dispensaries in New Jersey were banned from carrying vaporizer products such as cannabis cartridges, with the law limiting them to selling cannabis bud, topicals (lotions, ointments, etc.) and oral lozenges. Now, with a rule change brought forth by the Department of Health, dispensaries are authorized to sell cannabis cartridges, vape pens and other similar products.
Curaleaf New Jersey, based in Bellmawr, is one of the first dispensaries to offer cannabis cartridges, with sales of the product starting earlier today. There are five other dispensaries located throughout New Jersey, and it’s expected that most if not all will be offering the product soon (if they don’t already).
Expanding access to medical cannabis and allowing a more diverse list of products is a priority of the Health Department, and this move is an indication of that, says assistant health commissioner Jeff Brown.
Earlier this year the department released a new set of rules for the state’s medical cannabis program.
A judge is Michigan has stopped plans by state officials that would shutdown nearly 100 medical marijuana businesses.
Court of Claims Judge Stephen Borrello granted an injunction yesterday on the businesses’ closure. The injunction was requested by a lawyer representing one of the medical marijuana business that would have been shutdown. The state is currently reviewing the judge’s order.
Regulators on Tuesday, Sept. 11, 2018, extended the deadline to Dec. 15, 2018, for medical marijuana businesses to be licensed, allowing 108 facilities to continue operating while warning that 98 others would be issued cease-and-desist letters. Borrello’s order tells the state to allow all to keep operating.
This marks the third time the licensing deadline has been extended or softened as Michigan continues the process of more tightly regulating the medical cannabis industry under a 2016 law.
Too high — seven little letters and a space. Doesn’t seem so bad on the surface, right? There are plenty of four-letter words that might seem worse. But for new and experienced cannaseurs alike, four-letter words are nothing when compared to saying “too high” out loud.
Unfortunately, it’s an all-too-common part of the marijuana experience. One minute you’re riding a seriously righteous high, and the next minute you’re convinced the floor is going to open up and swallow you whole.
So what’s a too-high stoner to do? The cannabis experts at Honest Marijuana give you 15 remedies to help you down fast.
How To Sober Up When You’re Too High
1) Stop Smoking
This may seem like an obvious first step, but you’d be surprised how many people think that more of the same will make it all better. Probably has something to do with old saying, “Hair of the dog that bit you…”
Regardless, when you feel like you’ve gone too high, put the joint, blunt, or bong down and do something else for a while.
2) Battle The Blaze With CBD
Here’s a cool fact: cannabidiol (CBD) actually counteracts the psychedelic effects of THC. Add to that the wonderful news that CBD doesn’t have any major side effects of its own, and you’ve got a potent remedy for a bad trip.
We recommend keeping a stash of CBD oil on hand for the inevitable too-high emergencies that pop up now and again.
Sleep is an excellent remedy when you feel way too high. While you snooze, your body releases hormones that work to clean out your system and repair any problems.
Plus, you’ll be asleep, so you won’t have to deal with the brunt of the bad trip.
We recommend a short 30-minute nap if you can manage it. Any longer than that and you may feel even groggier later on. Be …